CCL2 and inflammatory bowel disease: While the biological role of CCL2 in CD and IBD are well recognized (Darkoh et al., 2014; Maharshak et al., 2010; Martin et al., 2019), the results from genetic association studies are not consistent and the disease outcomes could potentially differ by population studied (Chen et al., 2016).